PMA device
DISCOVISC Ophthalmic Viscosurgical Device
Alcon Laboratories · Aid, Surgical, Viscoelastic (LZP, Class III) · First FDA decision Mar 23, 2005, newest Dec 3, 2021Cataract
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
6
Naming "DISCOVISC Ophthalmic Viscosurgical"
MAUDE reports
0
Brand "DISCOVISC Ophthalmic Viscosurgical", since 2015
PubMed studies
0
Mentioning "DISCOVISC Ophthalmic Viscosurgical"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing DISCOVISC Ophthalmic Viscosurgical Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 3 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "DISCOVISC Ophthalmic Viscosurgical", any status and sponsor, newest update first.
- Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)Pivotal-lookingCompleted
Bausch & Lomb IncorporatedNot on our public-company list
NCT03511638 · 372 participants · Start May 9, 2018 · Primary completion Apr 1, 2019
Device: Bausch & Lomb DVisc40; Alcon VISCOAT® · For: Cataract
Sites: San Diego, California
- Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry ReadingsCompleted
Clinical Research Consultants, Inc.Not on our public-company list
NCT03751033 · 120 participants · Start Sep 7, 2018 · Primary completion Jan 6, 2020
Device: BSS; DiscoVisc · For: Cataract
Sites: Los Angeles, California; Brecksville, Ohio; Salt Lake City, Utah
- To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.Pivotal-lookingCompleted
Alcon ResearchNot on our public-company list
NCT00763360 · 184 participants · Start May 2008 · Primary completion Sep 2010
Device: DisCoVisc® · For: Cataract
Sites: Fort Worth, Texas
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DISCOVISC Ophthalmic Viscosurgical", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LZP
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "DISCOVISC Ophthalmic Viscosurgical"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LZP.
- PROVISC Ophthalmic Viscosurgical DeviceAlcon Research, Ltd. · PMA 2026
- Sodium Hyaluronate Ophthalmic Viscoelastic Devices (OVD)Johnson & Johnson Surgical Vision, Inc. · PMA 2024
- Amvisc & Amvisc Plus OvdBausch & Lomb, Inc. · PMA 2017
- Staarvisc II & Shellgel Sodium HyauronateAnika Therapeutics, Inc. · PMA 2012
- VISCOAT Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2026
- Cellugel(R) Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2016
- Ocucoat (2% Hydroxpropylmethylcellulose Solution)Bausch & Lomb, Inc. · PMA 2012
- Biolon (1% Sodium Hyaluronate for Ophthalmic Surgery)Altacor , Ltd. · PMA 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.